Bruce Johnson

Bruce Johnson is a seasoned executive in the biopharmaceutical industry, currently serving as the Chief Commercial Officer and Senior Vice President at GlycoMimetics, Inc. He has over 25 years of experience in the field, specializing in oncology and commercial development. His career includes significant roles at notable organizations such as Memorial Sloan Kettering, Sandoz, Novartis, AbbVie, and Cancer Expert Now, Inc., where he previously held the position of Executive Vice President and Chief Commercial Officer.124

Education and Background

Bruce Johnson holds a Bachelor of Arts in Microbiology from Miami University in Oxford, Ohio. He has pursued graduate studies in Biochemistry and Molecular Biology at Columbia University, as well as Marketing and Finance at Rutgers University School of Management.13

Professional Achievements

Throughout his career, Johnson has been instrumental in launching various successful oncology products, including Venclexta, Zometa, and Gleevec. He has a proven track record of leading multi-billion dollar commercial franchises and has been involved in developing new capabilities and improving profitability across different organizations.12 His leadership at Cancer Expert Now helped the company gain national recognition as one of the fastest-growing small companies in America by Inc. Magazine.1

Current Role

In his current role at GlycoMimetics, Johnson continues to leverage his extensive expertise to drive the commercialization of innovative therapies aimed at treating various cancers and rare diseases.24